Universe Pharmaceuticals INC
As of Oct 16, 2026 close
- Market cap
- $2.34M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.00$17.96
- Volume (live)
- -
- Avg. volume (3M)
- 48.28K
Universe Pharmaceuticals (UPC) Stock Price & Financial Analysis
Universe Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.93 - $4.10 |
|---|---|
| 52-Week High | $17.96 |
| 52-Week Low | $2.00 |
| Open | $4.10 |
| Volume (last close) | 7.81K |
| Average Volume (3M) | 48.28K |
| Revenue (TTM) | 37.04M |
|---|---|
| Net Income (TTM) | -852.71K |
| Free Cash Flow (TTM) | -17.30M |
| EPS (TTM) | −$3.00 |
| Profit Margin | -2.30% |
| Operating Margin | -28.88% |
| Return on Equity (ROE) | -1.53% |
| Debt to Equity | 0.17 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.34M |
|---|---|
| Shares Outstanding | 563.34K |
| Price to Sales (P/S) | 0.06 |
| Price to Book (P/B) | 0.04 |
| EV/EBITDA | -31.17 |
| 50-Day MA | $4.86 |
|---|---|
| 200-Day MA | $3.88 |
| 1-Year Change | −20.65% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Universe Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Universe Pharmaceuticals (UPC) has a market capitalization of $2.34M. The stock trades at 0.1× sales. Over the trailing twelve months it lost $852.71K on revenue of $37.04M and burned $17.30M of free cash flow. Revenue fell 22.4% year over year.
As of its latest reported balance sheet, it holds $27.56M in cash and securities against $9.55M of debt, a net cash position of $18.01M.
Universe Pharmaceuticals does not currently pay a dividend.
The share price is down 20.7% over the past year. At $3.93 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $2.00 to $17.96, above its 200-day moving average of $3.88.
Frequently Asked Questions About Universe Pharmaceuticals
What is the current stock price for UPC?
As of the Oct 16, 2026 close, UPC stock trades at $3.93. The 52-week range is $2.00–$17.96, with a day range of $3.93–$4.10.
What is the P/E ratio for UPC?
The P/E ratio (Price-to-Earnings) for UPC is shown in the Key Statistics section. This valuation metric helps compare Universe Pharmaceuticals INC to industry peers.
Does UPC pay dividends?
Universe Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for UPC?
Analyst ratings and recommendations for UPC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of UPC?
As of the Oct 16, 2026 close, Universe Pharmaceuticals's market capitalization is $2.2M, classifying it as a micro-cap company. Universe Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.